ROKIT Healthcare Inc. (KOSDAQ:376900)
South Korea · Delayed Price · Currency is KRW 91,200
-2,000 (-2.15%)
At close: Apr 10, 2026
ROKIT Healthcare Revenue
In the year 2025, ROKIT Healthcare had annual revenue of 26.25B KRW with 100.19% growth. ROKIT Healthcare had revenue of 9.58B in the quarter ending December 31, 2025, with 161.48% growth.
Revenue
26.25B
Revenue Growth
+100.19%
P/S Ratio
54.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.44T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.25B | 13.14B | 100.19% |
| Dec 31, 2024 | 13.11B | 693.67M | 5.59% |
| Dec 31, 2023 | 12.42B | 3.27B | 35.70% |
| Dec 31, 2022 | 9.15B | 2.41B | 35.76% |
| Dec 31, 2021 | 6.74B | 2.75B | 68.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 100.17B |
| Aimed Bio | 94.56B |
| JS Link | 19.32B |
| Qurient | 6.98B |
| Inventage Lab | 2.94B |
| IntoCell | 2.30B |
| AprilBio | 2.17B |